Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
Adult
Black or African American
/ statistics & numerical data
Asian
/ statistics & numerical data
End Stage Liver Disease
/ mortality
Female
Health Services Accessibility
Healthcare Disparities
/ ethnology
Hispanic or Latino
/ statistics & numerical data
Humans
Liver Transplantation
Male
Middle Aged
Severity of Illness Index
Tissue and Organ Procurement
United States
Waiting Lists
/ mortality
White People
/ statistics & numerical data
Journal
Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
27
01
2021
received:
17
11
2020
accepted:
17
03
2021
pubmed:
30
3
2021
medline:
13
1
2022
entrez:
29
3
2021
Statut:
ppublish
Résumé
The Model for End-Stage Liver Disease score may have eliminated racial disparities on the waitlist for liver transplantation (LT), but disparities prior to waitlist placement have not been adequately quantified. We aimed to analyze differences in patients who are listed for LT, undergo transplantation, and die from end-stage liver disease (ESLD), stratified by state and race/ethnicity. We analyzed two databases retrospectively, the Center for Disease Control Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) and the United Network for Organ Sharing (UNOS) databases, from 2014 to 2018. We included patients aged 25-64 years who had a primary cause of death of ESLD and were listed for transplant in the CDC WONDER or UNOS database. Our primary outcome was the ratio of listing for LT to death from ESLD-listing to death ratio (LDR). Our secondary outcome was the transplant to listing and transplant to death ratios. Chi-squared and multivariable linear regression evaluated for differences between races/ethnicities. There were 135,367 patients who died of ESLD, 54,734 patients who were listed for transplant, and 26,571 who underwent transplant. Patients were mostly male and White. The national LDR was 0.40, significantly lowest in Black patients (0.30), P < 0.001. The national transplant to listing ratio was 0.48, highest in Black patients (0.53), P < 0.01. The national transplant to death ratio was 0.20, lowest in Black patients (0.16), P < 0.001. States that had an above-mean LDR had a lower transplant to listing ratio but a higher transplant to death ratio. Multivariable analysis confirmed that Black race is significantly associated with a lower LDR and transplant to death ratio. Black patients face a disparity in access to LT due to low listing rates for transplant relative to deaths from ESLD.
Sections du résumé
BACKGROUND AND AIMS
The Model for End-Stage Liver Disease score may have eliminated racial disparities on the waitlist for liver transplantation (LT), but disparities prior to waitlist placement have not been adequately quantified. We aimed to analyze differences in patients who are listed for LT, undergo transplantation, and die from end-stage liver disease (ESLD), stratified by state and race/ethnicity.
APPROACH AND RESULTS
We analyzed two databases retrospectively, the Center for Disease Control Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) and the United Network for Organ Sharing (UNOS) databases, from 2014 to 2018. We included patients aged 25-64 years who had a primary cause of death of ESLD and were listed for transplant in the CDC WONDER or UNOS database. Our primary outcome was the ratio of listing for LT to death from ESLD-listing to death ratio (LDR). Our secondary outcome was the transplant to listing and transplant to death ratios. Chi-squared and multivariable linear regression evaluated for differences between races/ethnicities. There were 135,367 patients who died of ESLD, 54,734 patients who were listed for transplant, and 26,571 who underwent transplant. Patients were mostly male and White. The national LDR was 0.40, significantly lowest in Black patients (0.30), P < 0.001. The national transplant to listing ratio was 0.48, highest in Black patients (0.53), P < 0.01. The national transplant to death ratio was 0.20, lowest in Black patients (0.16), P < 0.001. States that had an above-mean LDR had a lower transplant to listing ratio but a higher transplant to death ratio. Multivariable analysis confirmed that Black race is significantly associated with a lower LDR and transplant to death ratio.
CONCLUSIONS
Black patients face a disparity in access to LT due to low listing rates for transplant relative to deaths from ESLD.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1523-1532Informations de copyright
© 2021 by the American Association for the Study of Liver Diseases.
Références
Murray CJL, Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, et al. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA 2018;319:1444-1472.
Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Netw Open 2020;3:e201997.
Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014;59:1144-1165.
United Network for Organ Sharing. Transplant trends. https://unos.org/data/transplant-trends/. Accessed January 4, 2021.
Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, Kamath PS, et al. Reduced access to liver transplantation in women: role of height, MELD exception scores, and renal function underestimation. Transplantation 2018;102:1710-1716.
Verna EC, Lai JC. Time for action to address the persistent sex-based disparity in liver transplant access. JAMA Surg 2020;155:545-547.
Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Racial and ethnic disparities in access to liver transplantation. Liver Transpl 2010;16:1033-1040.
Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ 2018;362:k2817.
Reid AE, Resnick M, Chang YC, Buerstatte N, Weissman JS. Disparity in use of orthotopic liver transplantation among Blacks and Whites. Liver Transpl 2004;10:834-841.
Eckhoff DE, McGuire BM, Young CJ, Sellers MT, Frenette LR, Hudson SL, et al. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation? Liver Transpl Surg 1998;4:499-505.
Nguyen GC, Segev DL, Thuluvath PJ. Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology 2007;45:1282-1289.
Jesse MT, Abouljoud M, Goldstein ED, Rebhan N, Ho C-X, Macaulay T, et al. Racial disparities in patient selection for liver transplantation: an ongoing challenge. Clin Transplant 2019;33:e13714.
Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008;300:2371-2378.
Julapalli VR, Kramer JR, El-Serag HB. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl 2005;11:1370-1378.
Bryce CL, Angus DC, Arnold RM, Chang CCH, Farrell MH, Manzarbeitia C, et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant 2009;9:2092-2101.
Wilder JM, Oloruntoba OO, Muir AJ, Moylan CA. Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation. Liver Transpl 2016;22:895-905.
Mathur AK, Ashby VB, Fuller DS, Zhang M, Merion RM, Leichtman A, et al. Variation in access to the liver transplant waiting list in the United States. Transplantation 2014;98:94-99.
Tapper EB, Korovaichuk S, Baki J, Williams S, Nikirk S, Waljee AK, et al. Identifying patients with hepatic encephalopathy using administrative data in the ICD-10 era. Clin Gastroenterol Hepatol 2021;19:604-606.
Ramrakhiani N, Le M, Yeo YH, Le A, Maeda M, Nguyen M. Validity of International Classification of Diseases, 10th revision, codes for cirrhosis. Dig Dis Sci 2020 Aug 19. https://doi.org/10.1159/000510981. [Epub ahead of print]
US Department of Health and Human Services. Organ Procurement and Transplantation Network. State data. https://optn.transplant.hrsa.gov/data/view-data-reports/state-data/. Accessed January 4, 2021.
Ross K, Patzer RE, Goldberg DS, Lynch RJ. Sociodemographic determinants of waitlist and posttransplant survival among end-stage liver disease patients. Am J Transplant 2017;17:2879-2889.
Yu JC, Neugut AI, Wang S, Jacobson JS, Ferrante L, Khungar V, et al. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer 2010;116:1801-1809.
Kirby JB, Kaneda T. Unhealthy and uninsured: exploring racial differences in health and health insurance coverage using a life table approach. Demography 2010;47:1035-1051.
. Health coverage by race and ethnicity: the potential impact of the Affordable Care Act. https://www.kff.org/disparities-policy/issue-brief/health-coverage-by-race-and-ethnicity-the-potential-impact-of-the-affordable-care-act/. Accessed June 11, 2020.
Kemmer N, Zacharias V, Kaiser TE, Neff GW. Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci 2009;54:1794-1797.
Wong RJ, Devaki P, Nguyen L, Cheung R, Nguyen MH. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry. Liver Transpl 2014;20:528-535.
Dakhoul L, Gawrieh S, Jones K, Ghabril M, McShane C, Orman E, et al. Racial disparities in liver transplantation for hepatocellular carcinoma are not explained by differences in comorbidities, liver disease severity, or tumor burden. Hepatol Commun 2018;3:52-62.
Walker RJ, Strom Williams J, Egede LE. Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci 2016;351:366-373.
White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology 2017;152:812-820.e5.
Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic fatty liver disease in Latinos. Clin Gastroenterol Hepatol 2016;14:5-12.
Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, et al. Race/ethnicity-specific disparities in hepatocellular carcinoma stage at diagnosis and its impact on receipt of curative therapies. J Clin Gastroenterol 2016;50:423-430.
Organ Procurement and Transplantation Network. Median MELD at transplant by donor service area and median PELD at transplant within the nation. https://optn.transplant.hrsa.gov/media/3180/mts_dsa_distribution_20190924.pdf. Published September 18, 2019. Accessed July 8, 2020.
Goldberg DS, French B, Forde KA, Groeneveld PW, Bittermann T, Backus L, et al. Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. JAMA 2014;311:1234-1243.
Axelrod DA, Guidinger MK, Finlayson S, Schaubel DE, Goodman DC, Chobanian M, et al. Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA 2008;299:202-207.
Cullaro G, Sarkar M, Lai JC. Sex-based disparities in delisting for being “too sick” for liver transplantation. Am J Transplant 2018;18:1214-1219.